SE8105425L - 2-amino-3-karbetoxiamino-6-(p-fluor-bensylamino)-pyridin-maleat - Google Patents

2-amino-3-karbetoxiamino-6-(p-fluor-bensylamino)-pyridin-maleat

Info

Publication number
SE8105425L
SE8105425L SE8105425A SE8105425A SE8105425L SE 8105425 L SE8105425 L SE 8105425L SE 8105425 A SE8105425 A SE 8105425A SE 8105425 A SE8105425 A SE 8105425A SE 8105425 L SE8105425 L SE 8105425L
Authority
SE
Sweden
Prior art keywords
carbethoxyamino
benzylamino
fluoro
amino
maleate
Prior art date
Application number
SE8105425A
Other languages
English (en)
Other versions
SE454693B (sv
Inventor
Bebenburg W Von
S Pauluhn
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of SE8105425L publication Critical patent/SE8105425L/sv
Publication of SE454693B publication Critical patent/SE454693B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8105425A 1980-09-13 1981-09-11 2-amino-3-karbetoxiamino-6-(p-fluor-bensylamino)-pyridin-maleat, forfarande for framstellning av detta och ett lekemedel med analgetisk och/eller antiflogistisk effekt SE454693B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3034638 1980-09-13

Publications (2)

Publication Number Publication Date
SE8105425L true SE8105425L (sv) 1982-03-14
SE454693B SE454693B (sv) 1988-05-24

Family

ID=6111900

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8105425A SE454693B (sv) 1980-09-13 1981-09-11 2-amino-3-karbetoxiamino-6-(p-fluor-bensylamino)-pyridin-maleat, forfarande for framstellning av detta och ett lekemedel med analgetisk och/eller antiflogistisk effekt

Country Status (31)

Country Link
US (1) US4481205A (sv)
JP (1) JPS5781465A (sv)
KR (1) KR860000585B1 (sv)
AR (1) AR229101A1 (sv)
AT (1) AT375924B (sv)
AU (1) AU541020B2 (sv)
BE (1) BE890331A (sv)
CA (1) CA1147736A (sv)
CH (1) CH646952A5 (sv)
CS (1) CS226037B2 (sv)
DD (1) DD201786A5 (sv)
DK (1) DK159878C (sv)
EG (1) EG15446A (sv)
ES (1) ES505423A0 (sv)
FI (1) FI79531C (sv)
FR (1) FR2490225B1 (sv)
GB (1) GB2084138B (sv)
GR (1) GR75777B (sv)
HU (1) HU182720B (sv)
IE (1) IE51547B1 (sv)
IL (1) IL63801A (sv)
IN (1) IN155674B (sv)
IT (1) IT1171520B (sv)
LU (1) LU83633A1 (sv)
NL (1) NL189856C (sv)
NO (1) NO160919C (sv)
PL (1) PL130030B1 (sv)
SE (1) SE454693B (sv)
SU (1) SU1091855A3 (sv)
YU (1) YU43037B (sv)
ZA (1) ZA816336B (sv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3416609A1 (de) * 1984-05-05 1985-11-07 Degussa Ag, 6000 Frankfurt 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)- pyridin-gluconat und pharmazeutische zubereitungen, die diese substanz enthalten
NO860825L (no) * 1985-03-23 1986-09-24 Degussa Fremgangsmaate til fremstilling av 2-amino-3-nitro-6-(4-fluor-benzylamino)-pyridin samt 2-amino-3-karbetoksyamino-6-(4-fluor-benzylamino)-pyridin.
JPH0568848U (ja) * 1991-11-18 1993-09-17 京都機械工具株式会社 チューブ絞り器
DE4327516A1 (de) * 1993-08-17 1995-02-23 Asta Medica Ag Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin
DE19625582A1 (de) * 1996-06-27 1998-01-02 Asta Medica Ag Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen die mit einer unphysiologisch hohen Zellsterberate einhergehen
DE19716984A1 (de) * 1997-04-23 1998-10-29 Asta Medica Ag Verfahren zur Herstellung von reinem Flupirtin-Maleat und dessen Modifikation A
US6187324B1 (en) * 1998-08-11 2001-02-13 Kabushiki Kaisha Ogi Kogei Cosmetic composition comprising at least one of Kumazasa extract and medicinal carbon
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
DE10327674A1 (de) * 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
US7741358B2 (en) * 2005-04-14 2010-06-22 N.V. Organon Crystal form of asenapine maleate
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
WO2009152647A1 (zh) 2008-06-20 2009-12-23 江苏恩华药业股份有限公司 芳烷基哌啶衍生物及其在制备镇痛、镇静药物中的应用
EP2361247A4 (en) * 2008-08-06 2012-08-08 Bionevia Pharmaceuticals Inc FLUPIRTINHYDROCHLORID-maleic acid co-crystal
DE102009023162B4 (de) * 2009-05-29 2011-07-07 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Flupirtin
CN102140077A (zh) * 2010-01-28 2011-08-03 范扶民 氟吡汀a晶型及其制备方法
WO2012004391A1 (en) 2010-07-09 2012-01-12 K.H.S. Pharma Holding Gmbh Process for the preparation of flupirtine maleate
CN102241626B (zh) * 2011-05-03 2013-07-03 北京华睿鼎信科技有限公司 一种马来酸氟吡汀的合成工艺
WO2013080215A1 (en) 2011-11-30 2013-06-06 Arch Pharmalabs Limited An improved process for the preparation of flupirtine and pharmaceutically acceptable salts thereof
CN103086963A (zh) * 2013-01-29 2013-05-08 吉林修正药业新药开发有限公司 一种马来酸氟吡汀a晶型化合物及中间体的合成方法
CN104086481B (zh) * 2014-07-18 2016-05-11 四川新斯顿制药股份有限公司 一种马来酸氟吡汀的合成方法
CN111100010A (zh) * 2019-12-30 2020-05-05 山东省越兴化工有限公司 一种对氟苄胺的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795858C2 (de) * 1968-07-19 1979-01-11 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Benzylaminopyridine
US3969361A (en) * 1972-05-10 1976-07-13 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler 2-Benzoyl-3-amino-pyridines

Also Published As

Publication number Publication date
KR830007556A (ko) 1983-10-21
FI79531C (sv) 1990-01-10
FI812836L (fi) 1982-03-14
AR229101A1 (es) 1983-06-15
IT1171520B (it) 1987-06-10
ZA816336B (en) 1982-09-29
YU43037B (en) 1989-02-28
FR2490225A1 (fr) 1982-03-19
NL189856C (nl) 1993-08-16
FI79531B (fi) 1989-09-29
IT8149272A0 (it) 1981-09-11
SE454693B (sv) 1988-05-24
ES8206481A1 (es) 1982-08-16
IE812055L (en) 1982-03-13
EG15446A (en) 1986-06-30
DK404681A (da) 1982-03-14
DK159878C (da) 1991-05-13
IN155674B (sv) 1985-02-23
AT375924B (de) 1984-09-25
BE890331A (fr) 1982-03-11
GB2084138A (en) 1982-04-07
YU215781A (en) 1984-02-29
JPH0259149B2 (sv) 1990-12-11
SU1091855A3 (ru) 1984-05-07
ATA393481A (de) 1984-02-15
ES505423A0 (es) 1982-08-16
CS226037B2 (en) 1984-03-19
AU541020B2 (en) 1984-12-13
PL130030B1 (en) 1984-07-31
IL63801A (en) 1984-10-31
GB2084138B (en) 1984-07-25
DK159878B (da) 1990-12-24
IL63801A0 (en) 1981-12-31
US4481205A (en) 1984-11-06
NL189856B (nl) 1993-03-16
CA1147736A (en) 1983-06-07
HU182720B (en) 1984-03-28
CH646952A5 (de) 1984-12-28
DD201786A5 (de) 1983-08-10
KR860000585B1 (ko) 1986-05-17
NL8104211A (nl) 1982-04-01
GR75777B (sv) 1984-08-02
PL232999A1 (sv) 1982-08-16
IE51547B1 (en) 1987-01-07
LU83633A1 (de) 1982-01-21
NO160919B (no) 1989-03-06
AU7516381A (en) 1982-03-25
JPS5781465A (en) 1982-05-21
NO160919C (no) 1989-06-14
FR2490225B1 (fr) 1985-09-06
NO813082L (no) 1982-03-15

Similar Documents

Publication Publication Date Title
SE8105425L (sv) 2-amino-3-karbetoxiamino-6-(p-fluor-bensylamino)-pyridin-maleat
FR2434803A1 (fr) Imides et bis-imides substitues a l'azote, utilisables comme corps intermediaires
FI96204C (sv) Förfarande för framställning av terapeutiskt användbara heterocykliska föreningar
ATE190838T1 (de) Injizierbare arzneizubereitungen enthaltend taxanderivate
ATE43828T1 (de) Hydroterphenyle.
MY117090A (en) Substituted benzamidines, their preparation and their use as pharmaceutical compounds
FR2430932A1 (fr) Metaphenylenediamines et compositions tinctoriales les contenant
NO854435L (no) Fremgangsmaate for fremstilling av polypeptider.
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
JPS5681852A (en) Spectral sensitizer for photoconductive substance and photoconductive composition containing it
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
LV10949A (lv) Aizvietoti 4-fenil-4piperidinkarboksamidi to iegusanas panemiens farmaceitiska kompozicija
JPS5772975A (en) 2-substituted phenylthiazole derviative, and medicine for peptic ulcer containing said derivative as active component
FR2373590A1 (fr) Solvants de colorants pour la preparation de papiers copiants sans carbone
DE3374005D1 (en) 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle
IE792328L (en) Derivatives of dihydropyrrole and tetrahydropyridine.
ES8403911A1 (es) Procedimiento de preparacion de mononitratos de 1.4,3.6- dianhidro-hexito sustituidos en 2-0 y 5-0
JPS5554379A (en) Liquid crystal composition
SE8200649L (sv) Polycykliska foreningar innehallande en dubbelbindning i d-ringen, sett for deras framstellning och farmaceutiska beredningar innehallande dem
EP0034721A3 (en) Polypeptide and its production and use
FR2378068A1 (fr) Preparations de matieres colorantes pour celluloses et matieres textiles cellulosiques et nouvelles matieres colorantes entrant dans ces preparations
ES8105367A1 (es) Perfeccionamientos en o relacionados con compuestos organi- cos
SE8503109D0 (sv) Cyclic prodrugs of antiinflammatory oxicams
FR2367739A1 (fr) Nouvelles anilines n-substituees utilisables notamment pour la preparation de matieres colorantes
IE32946L (en) Phenethylamine derivatives

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8105425-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8105425-6

Format of ref document f/p: F